Humana Inc vs Sprott Uranium Miners ETF — how do they compare? Humana Inc trades at $445 (market cap $46.49B), while Sprott Uranium Miners ETF trades at $46.6 (market cap $1.87B). The key difference: Humana Inc is far larger — about 24.9× Sprott Uranium Miners ETF's market cap, and Humana Inc pays a 0.91% dividend while Sprott Uranium Miners ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Sprott Uranium Miners ETF for 60 Days on average.
| HUM | URNM | |
|---|---|---|
Market Cap | $46.49B | $1.87B |
Volume | 2,567,704 | 1,586,926 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $409.85 | $83.99 |
52-Week Low | $163.67 | $46.09 |
Typical Hold Time | 53 Days | 60 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
URNM (Sprott Uranium Miners ETF) trades at $47.87, down 4.83% today amid bearish technical signals. The ETF faces selling pressure with 13 bearish moving average indicators versus zero bullish signals. Despite the near-term weakness, uranium fundamentals remain strong with spot prices up 21.25% over the past year according to Sprott Asset Management data from August 2026. Recent government commitments to nuclear energy and AI-driven power demand create long-term growth catalysts.
The uranium sector faces near-term volatility but offers compelling long-term exposure to nuclear energy expansion. Key risks include uranium price fluctuations and regulatory uncertainty, while opportunities stem from $17.5 billion in U.S. nuclear funding and growing AI power needs. Analyst sentiment leans bullish on the sector's structural supply deficit and rising demand from data centers and government initiatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →